TDT 067 Open Label Multi-Dose Onychomycosis Study

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

June 30, 2012

Conditions
Onychomycosis
Interventions
DRUG

TDT067 and Lamisil

Topical administration of TDT067 and single oral administration of 250 mg Lamisil tablet

Sponsors
All Listed Sponsors
collaborator

PPD Development, LP

INDUSTRY

lead

Celtic Pharma Development Services

INDUSTRY

NCT01790165 - TDT 067 Open Label Multi-Dose Onychomycosis Study | Biotech Hunter | Biotech Hunter